RET Extracellular Domain (human, recombinant)

RET Extracellular Domain (human, recombinant)

CAT N°: 33987
Price:

602.00 511.70

Rearranged during transfection (RET) is a receptor tyrosine kinase with roles in cell proliferation, survival, metabolism, and migration, as well as in the development of the peripheral and central nervous systems.{60954,60955} It is composed of an extracellular domain, containing four cadherin-like domains (CLDs), a calcium-binding site, and a cysteine-rich region, a transmembrane domain, and an intracellular kinase domain.{60954,60956} RET forms heterodimeric complexes with the glial cell line-derived neurotrophic factor (GDNF) ligands GDNF, neurturin (NRTN), artemin (ARTN), and persephin (PSPN), and the GDNF family co-receptors GFR?1-4, which induces autophosphorylation of the intracellular kinase domain and activates cellular signaling.{60956} Germline nonsense and/or missense mutations in RET decrease functional RET in gut tissue during development and are associated with Hirschsprung’s disease.{60954,60956} Loss-of-function mutations in RET are associated with congenital anomalies of the kidney and urinary tract (CAKUT) and renal agenesis.{60956} Gain-of-function mutations in RET are associated with medullary thyroid cancer, pheochromocytoma, and parathyroid hypoplasias, and RET gene fusions have been found in patients with lung, colon, or breast carcinomas.{60955,60956} Cayman’s RET Extracellular Domain (human, recombinant) protein can be used for enzyme activity assays.

We also advise you

TAF 10 Peptide

TAF 10 Peptide

TAF10 is one of many protein factors or coactivators associated with RNA polymerase II activity.{16903} One vial of this peptide...

€191.00
View